Roundview Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,906
Closed -$981K 306
2021
Q3
$981K Buy
6,906
+90
+1% +$13.2K 0.11% 184
2021
Q2
$1.06M Buy
6,816
+103
+2% +$16.7K 0.12% 176
2021
Q1
$1.04M Hold
6,713
0.13% 163
2020
Q4
$1M Sell
6,713
-277
-4% -$39.1K 0.14% 150
2020
Q3
$924K Sell
6,990
-2,642
-27% -$345K 0.15% 138
2020
Q2
$1.12M Sell
9,632
-9,771
-50% -$1.13M 0.19% 125
2020
Q1
$1.9M Buy
19,403
+9,490
+96% +$1.24M 0.4% 63
2019
Q4
$1.44M Buy
9,913
+36
+0.4% +$4.97K 0.27% 110
2019
Q3
$1.32M Buy
9,877
+31
+0.3% +$4K 0.28% 103
2019
Q2
$1.13M Sell
9,846
-103
-1% -$12.1K 0.25% 111
2019
Q1
$1.23M Buy
+9,949
New +$1.13M 0.29% 94

Other funds holding ZBH

Roundview Capital's ZBH Position: Q4 2021 in Review

Roundview Capital sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 6,906 shares — an estimated $981K sold.

Roundview Capital first reported a position in ZBH in Q1 2019 and held it in 11 quarters. The position peaked at $1.9M in Q1 2020. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Roundview Capital reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Roundview Capital sold 6,906 Zimmer Biomet shares in Q4 2021, an estimated $981K.
  • Roundview Capital first reported a position in Zimmer Biomet in Q1 2019 and held it in 11 quarters.
  • Roundview Capital's Zimmer Biomet position peaked at $1.9M in Q1 2020.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Roundview Capital's 13F filing for Q4 2021, filed 10 Feb 2022.